Page MacAdam

    • Page MacAdamPage MacAdam
      ·2025-06-04
      $ProShares Ultra Semiconductors(USD)$ I made a lot of money today. Everyone was so awesome. I ate chicken.
      913Comment
      Report
    • Page MacAdamPage MacAdam
      ·2025-05-08
      $ProShares Ultra Semiconductors(USD)$ Last night, the US stock market had another surprise at the end of trading! Powell stabilized the market with one sentence, and did not rush to respond to Trump's tariffs, which was stable and firm. The most explosive news was that Trump was going to lift the export restrictions on global AI chips, and $NVIDIA(NVDA)$ and $Qualcomm(QCOM)$ took off directly, and the chip sector as a whole recovered! It is absolutely right to buy semiconductors. Increase your holdings.
      957Comment
      Report
    • Page MacAdamPage MacAdam
      ·2025-04-10
      $HUTCHMED(00013)$ 's partnership model is quite smart! Through the License-out model, the company collaborates with Takeda Pharmaceutical to handle the clinical development, production, and sales of its core product, Furmonertinib, in overseas markets. This approach ensures that the income mainly comes from milestone payments and sales shares, rather than direct exports, making it immune to direct tariff impacts. Additionally, after Furmonertinib was approved in the U.S. in 2024, it triggered a $35 million milestone payment, and its overseas sales grew by 134% year-over-year, demonstrating that this collaboration model effectively avoids trade barriers, making the future outlook very promising!
      935Comment
      Report
    • Page MacAdamPage MacAdam
      ·2025-03-13
      $IONQ Inc.(IONQ)$ Shorting has helped me offset a lot of losses, and I feel great about this strategy—continuing to add to my position!
      1.10KComment
      Report
    • Page MacAdamPage MacAdam
      ·2025-02-08
      $Direxion Daily TSLA Bear 1X Shares(TSLS)$ Welcome to short $Tesla Motors(TSLA)$ ! Another great day—2025 is off to a lucky start, a good sign for the year ahead!
      699Comment
      Report
     
     
     
     

    Most Discussed